Conditional Survival: A Useful Concept to Provide Information on How Prognosis Evolves over Time

被引:186
作者
Hieke, Stefanie [1 ]
Kleber, Martina [2 ,3 ]
Koenig, Christine [2 ]
Engelhardt, Monika [2 ]
Schumacher, Martin [1 ]
机构
[1] Univ Freiburg, Med Ctr, Inst Med Biometry & Stat, D-79104 Freiburg, Germany
[2] Univ Freiburg, Dept Med 1, Hematol Oncol & Stem Cell Transplantat, Med Ctr, D-79104 Freiburg, Germany
[3] Univ Basel Hosp, Clin Internal Med, CH-4031 Basel, Switzerland
关键词
MULTIPLE-MYELOMA; STAGING SYSTEM;
D O I
10.1158/1078-0432.CCR-14-2154
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
Conditional survival (CS) is defined as the probability of surviving further t years, given that a patient has already survived s years after the diagnosis of a chronic disease. It is the simplest form of a dynamic prediction in which other events in the course of the disease or biomarker values measured up to time s can be incorporated. CS has attracted attention in recent years either in an absolute or relative form where the latter is based on a comparison with an age-adjusted normal population being highly relevant from a public health perspective. In its absolute form, CS constitutes the quantity of major interest in a clinical context. Given a clinical cohort of patients with a particular type of cancer, absolute CS can be estimated by conditional Kaplan-Meier estimates in strata defined, for example, by age and disease stage or by a conditional version of the Cox and other regression models for timeto-event data. CS can be displayed as a function of the prediction time s in parametric as well as nonparametric fashion. We illustrate the use of absolute CS in a large clinical cohort of patients with multiple myeloma. For investigating CS, it is necessary to ensure almost complete long-term follow-up of the patients enrolled in the clinical cohort and to consider potential age-stage migration as well as changing treatment modalities over time. CS provides valuable and relevant information on how prognosis develops over time. It also serves as a starting point for identifying factors related to long-term survival. (C) 2015 AACR.
引用
收藏
页码:1530 / 1536
页数:7
相关论文
共 24 条
[1]
Chromosomal Abnormalities Are Major Prognostic Factors in Elderly Patients With Multiple Myeloma: The Intergroupe Francophone du Myelome Experience [J].
Avet-Loiseau, Herve ;
Hulin, Cyrille ;
Campion, Loic ;
Rodon, Philippe ;
Marit, Gerald ;
Attal, Michel ;
Royer, Bruno ;
Dib, Mamoun ;
Voillat, Laurent ;
Bouscary, Didier ;
Caillot, Denis ;
Wetterwald, Marc ;
Pegourie, Brigitte ;
Lepeu, Gerard ;
Corront, Bernadette ;
Karlin, Lionel ;
Stoppa, Anne-Marie ;
Fuzibet, Jean-Gabriel ;
Delbrel, Xavier ;
Guilhot, Francois ;
Kolb, Brigitte ;
Decaux, Olivier ;
Lamy, Thierry ;
Garderet, Laurent ;
Allangba, Olivier ;
Lifermann, Francois ;
Anglaret, Bruno ;
Moreau, Philippe ;
Harousseau, Jean-Luc ;
Facon, Thierry .
JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (22) :2806-+
[2]
Improving overall survival and overcoming adverse prognosis in the treatment of cytogenetically high-risk multiple myeloma [J].
Bergsagel, P. Leif ;
Mateos, Maria-Victoria ;
Gutierrez, Norma C. ;
Rajkumar, S. Vincent ;
Miguel, Jesus F. San .
BLOOD, 2013, 121 (06) :884-892
[3]
Recent major improvement in long-term survival of younger patients with multiple myeloma [J].
Brenner, Hermann ;
Gondos, Adam ;
Pulte, Dianne .
BLOOD, 2008, 111 (05) :2521-2526
[4]
Conditional Survival after Hepatic Resection for Hepatocellular Carcinoma in Cirrhotic Patients [J].
Cucchetti, Alessandro ;
Piscaglia, Fabio ;
Cescon, Matteo ;
Ercolani, Giorgio ;
Terzi, Eleonora ;
Bolondi, Luigi ;
Zanello, Matteo ;
Pinna, Antonio D. .
CLINICAL CANCER RESEARCH, 2012, 18 (16) :4397-4405
[5]
DURIE BGM, 1975, CANCER, V36, P842, DOI 10.1002/1097-0142(197509)36:3<842::AID-CNCR2820360303>3.0.CO
[6]
2-U
[7]
European Myeloma Network recommendations on the evaluation and treatment of newly diagnosed patients with multiple myeloma [J].
Engelhardt, Monika ;
Terpos, Evangelos ;
Kleber, Martina ;
Gay, Francesca ;
Waesch, Ralph ;
Morgan, Gareth ;
Cavo, Michele ;
van de Donk, Niels ;
Beilhack, Andreas ;
Bruno, Benedetto ;
Johnsen, Hans Erik ;
Hajek, Roman ;
Driessen, Christoph ;
Ludwig, Heinz ;
Beksac, Meral ;
Boccadoro, Mario ;
Straka, Christian ;
Brighen, Sara ;
Gramatzki, Martin ;
Larocca, Alessandra ;
Lokhorst, Henk ;
Magarotto, Valeria ;
Morabito, Fortunato ;
Dimopoulos, Meletios A. ;
Einsele, Hermann ;
Sonneveld, Pieter ;
Palumbo, Antonio .
HAEMATOLOGICA, 2014, 99 (02) :232-242
[8]
Gospodarowicz MK., 2006, Prognostic factors in cancer
[9]
International staging system for multiple myeloma [J].
Greipp, PR ;
San Miguel, J ;
Durie, BGM ;
Crowley, JJ ;
Barlogie, B ;
Bladé, J ;
Boccadoro, M ;
Child, JA ;
Harousseau, JL ;
Kyle, RA ;
Lahuerta, JJ ;
Ludwig, H ;
Morgan, G ;
Powles, R ;
Shimizu, K ;
Shustik, C ;
Sonneveld, P ;
Tosi, P ;
Turesson, I ;
Westin, J .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (15) :3412-3420
[10]
Getting More Out of Survival Data by Using the Hazard Function [J].
Hess, Kenneth R. ;
Levin, Victor A. .
CLINICAL CANCER RESEARCH, 2014, 20 (06) :1404-1409